response to abemaciclib in the neomonarch trial
Published 5 years ago • 150 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
1:43
electra: elacestrant and abemaciclib in patients with er , her2- breast cancer
-
1:33
ongoing trial of abemaciclib and pembrolizumab in hr /her2-negative breast cancer
-
3:06
age-stratified findings from the monarche trial of abemaciclib in breast cancer
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
2:20
an overview of the monarch and neomonarch trials in breast cancer
-
18:29
new frontiers in triple negative breast cancer
-
59:59
nbe update on adjuvant systemic therapy in breast cancer dr joydeep ghosh
-
56:27
ccf webinar: a clinical trial for a potential new ther2apy for biliary tract cancers
-
2:23
an overview of the neomonarch trial in hr /her2- breast cancer
-
2:10
monarche: adjuvant abemaciclib endocrine therapy in patients with hr , her2- high-risk ebc
-
0:52
exploring abemaciclib for the treatment of brain metastases in hr /her2- breast cancer
-
4:19
monarche results: abemaciclib plus endocrine therapy in high-risk early breast cancer
-
0:50
next steps beyond the monarch 1 trial in breast cancer
-
1:19
advantages to treating hr patients with breast cancer with abemaciclib
-
1:46
comment: monarch 3 trial: abemaciclib for advanced breast cancer
-
1:41
dr. harold j. burstein on cdk4/cdk6 inhibitor abemaciclib in breast cancer
-
1:41
postmonarch: abemaciclib with fulvestrant in pretreated hr /her2- breast cancer
-
5:06
safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
2:28
expert discusses promise of abemaciclib for breast cancer treatment
-
1:48
natalee and monarche: ribociclib and abemaciclib in hr /her2- breast cancer
-
0:48
dr. william sikov on triple-negative breast cancer patients not responding to treatment